EDIZIONI MINERVA MEDICA S.p.A.

Dear Doctor,

We are pleased to inform you that the articles listed below have been the most cited in the past few years.

Your contribution as Reader, Author or Reviewer helped the Journal improve its renown and worldwide visibility and trustworthiness.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 September;59(3):241-68
Prostate-specific membrane antigen as a target for cancer imaging and therapy
Kiess A. P., Banerjee S. R., Mease R. C., Rowe S. P., Rao A., Foss C. A., Chen Y., Yang X., Cho S. Y., Nimmagadda S., Pomper M. G.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 June;58(2):193-206
Hybrid tracers for sentinel node biopsy
Van Den Berg N. S., Buckle T., Kleinjan G. I., Klop W. M., Horenblas S., Van Der Poel H. G., Valdés-Olmos R. A., Van Leeuwen F. I.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 June;58(2):127-39
Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from “open and see” to “see and open”
Valdés Olmos R. A., Rietbergen D. D. D., Vidal-Sicart S., Manca G., Giammarile F., Mariani G.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 June;58(2):207-15
The GOSTT concept and hybrid mixed/virtual/augmented reality environment radioguided surgery
Valdés Olmos R. A., Vidal-Sicart S., Giammarile F., Zaknun J. J., Van Leeuwen F. W., Mariani G.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 June;58(2):140-60
Contribution of perioperative imaging to radioguided surgery
Vidal-Sicart S., Rioja M. E., Paredes P., Keshtgar M. R., Valdés Olmos R. A.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):18-38
89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?
Van Dongen G. A., Huisman M. C., Boellaard R., Harry Hendrikse N., Windhorst A. D., Visser G. W., Molthoff C. F., Vugts D. J.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):39-57
Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles
Peeters S. G., Zegers C. M., Yaromina A., Van Elmpt W., Dubois L., Lambin P.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 March;58(1):85-93
Diagnostic performance of FDG PET or PET/CT in prosthetic infection after arthroplasty: a meta-analysis
Jin H., Yuan L., Li C., Kan Y., Hao R., Yang J.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 June;58(2):114-26
Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue
Manca G., Volterrani D., Mazzarri S., Duce V., Svirydenka A., Giuliano A., Mariani G.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2014 March;58(1):66-73
18F-FDG PET-CT imaging in the neoadjuvant setting for stages II-III breast cancer: association of loco‑regional SUVmax with classical prognostic factors
García García-Esquinas M., García-Sáenz J. A., Arrazola García J., Enrique Fuentes Ferrer M., Furió V., Rodriguez Rey C., Román J. M., Carreras Delgado J. L.

.